14-Methoxymetopon, a very potent mu-opioid receptor-selective analgesic with an unusual pharmacological profile (Q34169931)

31 July 2017

title

14-Methoxymetopon, a very potent mu-opioid receptor-selective analgesic with an unusual pharmacological profile (English)

1 reference

31 July 2017

0 references

1 reference

Helmut Schmidhammer

6

0 references

author name string

Michael A King

1

1 reference

31 July 2017

Wendy Su

2

1 reference

31 July 2017

Claire L Nielan

3

1 reference

31 July 2017

Albert H Chang

4

1 reference

31 July 2017

Johannes Schütz

5

1 reference

31 July 2017

Gavril W Pasternak

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

European Journal of Pharmacology

31 July 2017

published in

1 reference

31 July 2017

volume

459

1 reference

31 July 2017

issue

2-3

1 reference

31 July 2017

page(s)

203-209

1 reference

Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Opiate receptors in mice: Genetic differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

3‐Methoxynaltrexone, a selective heroin/morphine‐6β‐glucuronide antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

14-methoxymetopon, a potent opioid, induces no respiratory depression, less sedation, and less bradycardia than sufentanil in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Highly potent novel opioid receptor agonist in the 14-alkoxymetopon series.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Intrathecal morphine in mice: a new technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Dissociation of morphine's analgesic and respiratory depressant actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Separation of morphine analgesia from physical dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Naloxonazine actions in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Autoradiographic analysis of mu1, mu2, and delta opioid binding in the central nervous system of C57BL/6BY and CXBK (opioid receptor-deficient) mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Evidence for differential opioid mu 1- and mu 2-receptor-mediated regulation of heart rate in the conscious rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Antisense mapping: assessing functional significance of genes and splice variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Opiate Analgesia: Evidence for Mediation by a Subpopulation of Opiate Receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Biochemical and pharmacological evidence for opioid receptor multiplicity in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Differential blockade by naloxonazine of two mu opiate actions: analgesia and inhibition of gastrointestinal transit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Strain differences in opiate receptors in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Cloning and pharmacological characterization of a rat mu opioid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Antagonism of heroin and morphine self-administration in rats by the morphine-6beta-glucuronide antagonist 3-O-methylnaltrexone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

mu opiate receptor: cDNA cloning and expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Classification of multiple morphine and enkephalin binding sites in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Signal transduction efficacy of the highly potent mu opioid agonist 14-methoxymetopon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902821-2

10.1016/S0014-2999(02)02821-2

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference